Evaluation of Airtraq in Pediatric

This study has been completed.
Sponsor:
Information provided by:
King Khaled Eye Specialist Hospital
ClinicalTrials.gov Identifier:
NCT00917566
First received: June 9, 2009
Last updated: November 18, 2009
Last verified: November 2009
  Purpose

This study indented to evaluate the use of Optical laryngoscope in pediatric


Condition Intervention
Intubation
Device: Airtraq
Device: Macintoch

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Official Title: Evaluation of Airtraq in Pediatric Population: A Prospective Randomized Study

Further study details as provided by King Khaled Eye Specialist Hospital:

Primary Outcome Measures:
  • Duration of intubation [ Time Frame: two minutes ] [ Designated as safety issue: No ]

Estimated Enrollment: 50
Study Start Date: April 2009
Study Completion Date: November 2009
Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Airtraq group
Use Airtraq for intubation
Device: Airtraq
intubation with airtraq
Other Name: Optical laryngoscope
Active Comparator: Macintoch gorup
Use Macintoch laryngoscope for intubation
Device: Macintoch
use Macintoch laryngoscope for intubation
Other Name: Standard laryngoscope

Detailed Description:

The authors are welling to study how intubation will differ if Airtraq optical laryngoscope used in pediatrics

  Eligibility

Ages Eligible for Study:   2 Years to 10 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Healthy children undergoing general anesthesia required tracheal intubation.

Exclusion Criteria:

  • History of difficult intubation.
  • Risk of aspiration.
  • Children with cardiovascular disease.
  • Children with respiratory disease.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00917566

Locations
Saudi Arabia
king Khaled Eye Specialist hospital
Riyadh, Saudi Arabia, 11462
Sponsors and Collaborators
King Khaled Eye Specialist Hospital
Investigators
Principal Investigator: Waleed Riad, MD, AB, SB King Khaled Eye Specialist Hospital
  More Information

No publications provided

Responsible Party: Waleed Riad, King khaled Eye specialist hospital
ClinicalTrials.gov Identifier: NCT00917566     History of Changes
Other Study ID Numbers: RP 0909
Study First Received: June 9, 2009
Last Updated: November 18, 2009
Health Authority: Saudi Arabia: Ministry of Health

Keywords provided by King Khaled Eye Specialist Hospital:
Airtraq
Pediatric

ClinicalTrials.gov processed this record on August 19, 2014